Renal · Urology
The facts most likely to be tested
Stress incontinence results from urethral hypermobility or intrinsic sphincter deficiency causing leakage with increased intra-abdominal pressure.
Urge incontinence is characterized by detrusor overactivity leading to a sudden, intense urgency to void.
Overflow incontinence presents with urinary retention, post-void residual volume >200 mL, and constant dribbling.
First-line treatment for stress incontinence is pelvic floor muscle training (Kegel exercises) and lifestyle modifications.
First-line pharmacotherapy for urge incontinence is antimuscarinic agents (e.g., oxybutynin) or beta-3 adrenergic agonists (e.g., mirabegron).
Functional incontinence occurs in patients with cognitive impairment or physical disability who cannot reach the toilet in time despite normal bladder function.
Urodynamic testing is the gold standard diagnostic study for complex or refractory cases of incontinence to differentiate between detrusor instability and sphincter incompetence.
Vignette unlocked
A 68-year-old female presents with a 4-month history of involuntary urine loss. She reports that she leaks small amounts of urine whenever she coughs, sneezes, or lifts heavy grocery bags. She denies any urgency, frequency, or nocturia. Physical examination reveals a positive cough stress test and urethral hypermobility on pelvic exam. Her post-void residual volume is 30 mL.
What is the most appropriate initial management for this patient?
Pelvic floor muscle training
The patient's presentation of leakage with increased intra-abdominal pressure and a positive cough stress test is diagnostic of stress incontinence, for which pelvic floor muscle training is the first-line intervention.
Full handout
High yield triage
Etiology / Epidemiology
Common in elderly women; risk factors include multiparity, obesity, and pelvic surgery.
Clinical Manifestations
Stress: leakage with increased intra-abdominal pressure. Urge: detrusor overactivity with sudden, intense need.
Diagnosis
Urodynamic testing is the gold standard; post-void residual (PVR) >200 mL suggests overflow.
Treatment
Stress: Pelvic floor exercises. Urge: Oxybutynin. Avoid anticholinergics in narrow-angle glaucoma.
Prognosis
High impact on quality of life; skin breakdown and recurrent UTIs are primary complications.
Full handout
Epidemiology & Etiology
Prevalence increases with age, often categorized by the DIAPPERS mnemonic (Delirium, Infection, Atrophic vaginitis, Pharmaceuticals, Psychological, Endocrine, Restricted mobility, Stool impaction). Multiparity and vaginal delivery are primary mechanical risk factors for stress incontinence. Obesity exacerbates intra-abdominal pressure, while neurologic disease (e.g., MS, Parkinson's) often drives urge incontinence.
Pertinent Anatomy
The pelvic floor muscles (levator ani) provide structural support to the bladder neck. The urethral sphincter maintains closure via sympathetic tone. Loss of urethral hypermobility or intrinsic sphincter deficiency leads to stress incontinence.
Pathophysiology
Stress incontinence results from weakened pelvic floor support causing bladder neck descent. Urge incontinence involves detrusor overactivity, where the bladder contracts prematurely despite low volume. Overflow incontinence stems from detrusor underactivity or bladder outlet obstruction, leading to chronic retention and constant dribbling.
Clinical Manifestations
Stress incontinence presents as leakage during coughing, sneezing, or lifting. Urge incontinence is characterized by urinary urgency and nocturia. Overflow incontinence manifests as weak stream and incomplete emptying. Red flags include hematuria, pelvic mass, or neurologic deficits requiring urgent imaging.
Diagnosis
Initial evaluation includes a voiding diary and urinalysis to rule out infection. Urodynamic testing is the gold standard for confirming bladder pressure dynamics. A post-void residual (PVR) volume >200 mL is diagnostic for overflow incontinence, while <50 mL is generally considered normal.
Treatment
Stress incontinence is managed with Kegel exercises and weight loss; surgery (e.g., mid-urethral sling) is reserved for refractory cases. Urge incontinence is treated with Oxybutynin or Mirabegron. Contraindications for anticholinergics include narrow-angle glaucoma and urinary retention. Overflow requires intermittent catheterization.
Prognosis
Chronic incontinence leads to dermatitis and recurrent urinary tract infections. Patients require monitoring for renal impairment if overflow is chronic. Quality of life scores improve significantly with targeted behavioral and pharmacological interventions.
Differential Diagnosis
Stress Incontinence: leakage with Valsalva
Urge Incontinence: sudden, uncontrollable urge
Overflow Incontinence: high PVR, constant dribbling
Functional Incontinence: physical/cognitive barrier to toilet
Transient Incontinence: reversible causes like DIAPPERS